In vivo transcription of a progesterone-responsive gene is specifically inhibited by a triplex-forming oligonucleotide.

AUTOR(ES)

Ing, N H

RESUMO

Oligonucleotides provide novel reagents for inhibition of gene expression because of their high affinity binding to specific nucleotide sequences. We describe a 38 base, single-stranded DNA that forms a triple helix or 'triplex' on progesterone response elements of a target gene. This triplex-forming oligonucleotide binds with a Kd = 100 nM at 37 degrees C and physiological pH, and blocks binding of progesterone receptors to the target. Furthermore, it completely inhibited progesterone receptor-dependent transcription in vitro. To approach in vivo conditions, triplex-forming oligonucleotides were tested in cell transfection studies. The derivation of the oligonucleotides with cholesterol enhanced their cellular uptake and nuclear concentration by at least four-fold. The cholesterol-derivatized triplex-forming oligonucleotide specifically inhibited transcription of the PRE-containing reporter gene in cells when applied to the medium at micromolar concentrations. This is the first demonstration of steroid-responsive gene inhibition by triplex formation and joins the growing body of evidence indicating that oligonucleotides have therapeutic potential.

Documentos Relacionados

• Selective inhibition of transcription of the Ets2 gene in prostate cancer cells by a triplex-forming oligonucleotide
• Triplex-forming oligonucleotide target sequences in the human genome
• Gene activation by triplex-forming oligonucleotide coupled to the activating domain of protein VP16.
• Targeted inhibition of transcription elongation in cells mediated by triplex-forming oligonucleotides
• Peptide conjugates for chromosomal gene targeting by triplex-forming oligonucleotides